StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
OKUR

OnKure Therapeutics, Inc.

OKUR Nasdaq Pharmaceutical Preparations EDGAR ↗
$4.02
+0.02 +0.50%

Key statistics

from XBRL data in SEC filings
Market cap
$162M
Revenue (TTM)
$0.00
Net income (TTM)
-$58.7M
EPS (TTM)
$-4.32
P/E ratio
Dividend yield
Free cash flow
-$51.9M
Cash
$192M
Total assets
$199M
Gross margin
52-week range
$1.91 – $5.38

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Director or officer change; Shareholder vote results Jun 4, 2026 8-K Results of operations (earnings release) May 5, 2026 10-Q Quarter ended 2026-03-31 May 5, 2026 8-K Entered a material agreement; Unregistered sale of equity; Director or officer change; Other events Mar 30, 2026 10-K Fiscal year ended 2025-12-31 Mar 12, 2026 8-K Results of operations (earnings release) Mar 12, 2026 8-K Entered a material agreement Nov 6, 2025 10-Q Quarter ended 2025-09-30 Nov 6, 2025 8-K Results of operations (earnings release) Nov 6, 2025 10-Q Quarter ended 2025-06-30 Aug 12, 2025 8-K Results of operations (earnings release) Aug 12, 2025 8-K Regulation FD disclosure Jun 26, 2025 8-K Shareholder vote results May 28, 2025 10-Q Quarter ended 2025-03-31 May 6, 2025 8-K Results of operations (earnings release) May 6, 2025 8-K Results of operations (earnings release) Mar 10, 2025 10-K Fiscal year ended 2024-12-31 Mar 10, 2025 8-K Regulation FD disclosure; Other events Dec 10, 2024 8-K Changed accountants; Other events Nov 7, 2024 10-Q Quarter ended 2024-09-30 Nov 7, 2024 8-K Completed an acquisition or disposition; Unregistered sale of equity; Modified rights of security holders; Change in control; Director or officer change; Amended charter or bylaws; Item 5.05; Item 5.06; Regulation FD disclosure Oct 8, 2024 8-K Shareholder vote results Oct 2, 2024 8-K Other events Sep 20, 2024 8-K Director or officer change Sep 13, 2024 10-Q Quarter ended 2024-06-30 Aug 13, 2024 8-K Results of operations (earnings release) Aug 13, 2024 8-K Entered a material agreement; Unregistered sale of equity; Change in control; Director or officer change; Regulation FD disclosure May 13, 2024 10-Q Quarter ended 2024-03-31 May 7, 2024 8-K Results of operations (earnings release) May 7, 2024 10-K/A Fiscal year ended 2023-12-31 Apr 26, 2024 10-K Fiscal year ended 2023-12-31 Mar 28, 2024 8-K Results of operations (earnings release) Mar 28, 2024 8-K Exit or disposal costs Feb 23, 2024 8-K Exit or disposal costs; Other events Dec 14, 2023 10-Q Quarter ended 2023-09-30 Nov 13, 2023 8-K Results of operations (earnings release) Nov 13, 2023 8-K Other events Oct 30, 2023 8-K Regulation FD disclosure; Other events Oct 10, 2023 10-Q Quarter ended 2023-06-30 Aug 10, 2023 8-K Results of operations (earnings release) Aug 10, 2023